Cancer Society says PHARMAC review doesn't go far enough

NewsTalk ZB

3 March 2021 - A review of drug buying agency PHARMAC is being described as long overdue.

It'll cover the drug funding agency's decision-making processes, but won't delve into budgets, due to 'commercial sensitivities'.

Cancer Society medical director Dr Chris Jackson told Mike Hosking we need to work out how we can see whether PHARMAC is delivering what it's supposed to.

Read Newstalk ZB article

Michael Wonder

Posted by:

Michael Wonder